Topic
stock-moves
1 stories related to this topic, newest first.
New York Postscience7 hrs ago
Definium Shares Rise 55% After LSD-Based Drug Meets Main Goal in Depression Trial
Definium Therapeutics reported that a single dose of its experimental drug DT120 reduced major depression symptoms in a late-stage trial. Shares jumped 55% to a more than four-year high.